Gentex Corporation has acquired eSight to develop advanced vision enhancement technologies for individuals with visual impairments, aiming to leverage its manufacturing expertise to improve product accessibility and functionality.
Information on the Target
eSight is a leading provider of vision enhancement technologies dedicated to improving the quality of life for individuals living with visual impairments. This wearable assistive technology enables users to carry out daily activities by significantly enhancing their vision, even for those with over 20 distinct ocular disorders. Through the use of high-definition cameras, proprietary algorithms, and a powerful processing platform, eSight devices facilitate improved real-time imaging via high-resolution screens, frequently allowing users to achieve clarity comparable to 20/20 vision.
The innovation behind eSight has garnered attention for its potential impact on millions of individuals facing challenges related to low vision. By combining advanced technology with user-friendly design, eSight is at the forefront of enhancing the everyday lives of those with visual impairments, integrating seamlessly into their routines.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
The assistive technology industry in the United States has been evolving rapidly, fueled by advancements in technology and increasing demand for solutions that cater to diverse human experiences and needs. The population of individuals with disabilities, including visual impairme
Similar Deals
Walgreens Boots Alliance, Inc. → Cencora, Inc.
2025
Dassault Systèmes → Click Therapeutics
2025
Danaher Corporation → Innovaccer Inc.
2025
NAMSA → WuXi AppTec's U.S. medical device testing operations
2025
Edwards Lifesciences → Innovalve Bio Medical Ltd.
2024
Gentex Corporation
invested in
eSight
in 2024
in a Other Corporate deal